scholarly journals Weight History and All-Cause and Cause-Specific Mortality in Three Prospective Cohort Studies

2017 ◽  
Vol 166 (9) ◽  
pp. 613 ◽  
Author(s):  
Edward Yu ◽  
Sylvia H. Ley ◽  
JoAnn E. Manson ◽  
Walter Willett ◽  
Ambika Satija ◽  
...  
2017 ◽  
Vol 27 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Long-Gang Zhao ◽  
Hong-Lan Li ◽  
Jiang-Wei Sun ◽  
Yang Yang ◽  
Xiao Ma ◽  
...  

2019 ◽  
Vol 38 (3) ◽  
pp. 1180-1187 ◽  
Author(s):  
Long-Gang Zhao ◽  
Xiao-Ou Shu ◽  
Hong-Lan Li ◽  
Jing Gao ◽  
Li-Hua Han ◽  
...  

2019 ◽  
Vol 124 (8) ◽  
pp. 1266-1275 ◽  
Author(s):  
Marta Guasch-Ferré ◽  
Geng Zong ◽  
Walter C. Willett ◽  
Peter L. Zock ◽  
Anne J. Wanders ◽  
...  

2013 ◽  
Vol 98 (4) ◽  
pp. 1032-1041 ◽  
Author(s):  
Jung Eun Lee ◽  
Dale F McLerran ◽  
Betsy Rolland ◽  
Yu Chen ◽  
Eric J Grant ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
Y Wang ◽  
J Nie ◽  
H Yu

Abstract Background What is more, some recent meta-analysis have demonstrated the sex difference between smoking, diabetes, and atrial fibrillation, and the risk of CVD mortality. Whether and to what extent the excess risk of cause-specific mortality from CVD death conferred by hypertension differs among women and men remain unclear. Objective A systematic review with meta-analysis was performed to explore whether and to what extent the excess risk of cause-specific mortality from CVD death conferred by hypertension differs among women and men. Methods PubMed and EMBASE was systematically searched for prospective cohort studies published from inception to 7 October 2017. Eligible studies reported sex-specific relative risk (RR) estimates for mortality of all-cause, CVD, coronary heart disease (CHD) and stroke associated with hypertension. The data were pooled using random effects models with inverse variance weighting, and estimates of the women-to-men ratio of RRs (RRR) for each outcomes were derived. Results Twenty-four studies with 2,939,659 participants were included in this meta-analysis. The RR for CHD mortality associated with hypertension compared with no hypertension was 2.24 (95% CI 2.03–2.46) in women and 1. 72 (1.61–1.84) in men. The multiple-adjusted RRR for CHD mortality was 22% greater in women with hypertension than in men with hypertension (RRR 1.22, 95% CI 1.03–1.44) with no significant heterogencity between studies (I2=45%, P=0.11, Figure 1). No evidence was observed sex difference in the relationship between hypertension and the mortality from all-cause, CVD and stroke. Furthermore, the subgroup analyses showed that the pooled RRR for all-cause mortality, CVD and stroke mortality were not significantly associated with cohort region, the duration of follow-up, mean age of participants and the publication year of studies. Conclusions Hypertension is a major risk factor for all-cause, CVD, CHD and stroke among women and men. Moreover, women with hypertension have more than a 22% higher risk of CHD mortality compared with men with hypertension. Further studies need to identify the biological and/or lifestyle mechanisms involved in sex differences driving these associations.


Sign in / Sign up

Export Citation Format

Share Document